JP3757368B2 - Antibacterial hypoallergenic cosmetic - Google Patents
Antibacterial hypoallergenic cosmetic Download PDFInfo
- Publication number
- JP3757368B2 JP3757368B2 JP01751297A JP1751297A JP3757368B2 JP 3757368 B2 JP3757368 B2 JP 3757368B2 JP 01751297 A JP01751297 A JP 01751297A JP 1751297 A JP1751297 A JP 1751297A JP 3757368 B2 JP3757368 B2 JP 3757368B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- added
- ether
- oil
- glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 29
- 239000002537 cosmetic Substances 0.000 title claims description 27
- 230000000774 hypoallergenic effect Effects 0.000 title claims description 5
- 244000062730 Melissa officinalis Species 0.000 claims description 34
- 239000000284 extract Substances 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 2
- 150000001346 alkyl aryl ethers Chemical class 0.000 claims 2
- 150000001983 dialkylethers Chemical class 0.000 claims 2
- 239000000469 ethanolic extract Substances 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- -1 etc. Substances 0.000 description 31
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 24
- 239000012071 phase Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000008213 purified water Substances 0.000 description 14
- 229940058015 1,3-butylene glycol Drugs 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 235000019437 butane-1,3-diol Nutrition 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 150000005846 sugar alcohols Polymers 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 150000005215 alkyl ethers Chemical class 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 208000035824 paresthesia Diseases 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 206010040880 Skin irritation Diseases 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 235000019388 lanolin Nutrition 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 230000036556 skin irritation Effects 0.000 description 6
- 231100000475 skin irritation Toxicity 0.000 description 6
- 229940121375 antifungal agent Drugs 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003429 antifungal agent Substances 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 239000000440 bentonite Substances 0.000 description 4
- 229910000278 bentonite Inorganic materials 0.000 description 4
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OOWQBDFWEXAXPB-UHFFFAOYSA-N 1-O-palmitylglycerol Chemical compound CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940051250 hexylene glycol Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- NRWMBHYHFFGEEC-KTKRTIGZSA-N (9Z)-1-O-octadec-9-enyl glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCC(O)CO NRWMBHYHFFGEEC-KTKRTIGZSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OOWQBDFWEXAXPB-IBGZPJMESA-N 1-O-hexadecyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)CO OOWQBDFWEXAXPB-IBGZPJMESA-N 0.000 description 1
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical class COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229940122511 Sebum inhibitor Drugs 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 240000002871 Tectona grandis Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940063656 aluminum chloride Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 231100000017 mucous membrane irritation Toxicity 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- PFYOXQQFOSJVRA-UHFFFAOYSA-N octyl 2-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1N(C)C PFYOXQQFOSJVRA-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000021148 sequestering of metal ion Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- HLWRUJAIJJEZDL-UHFFFAOYSA-M sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC([O-])=O HLWRUJAIJJEZDL-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- IFYFNVDTVZKNBZ-UHFFFAOYSA-N tetradecyl 2-hydroxybenzoate Chemical compound CCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1O IFYFNVDTVZKNBZ-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
この発明は、優れた抗菌性を有し、細菌,カビなどの微生物により汚染されることのない、安定で且つ皮膚に対する刺激性の低い化粧料に関する。さらに詳しくは、多価アルコール及び多価アルコールのアルキルエーテルより選んだ1種又は2種以上と、メリッサ(Melissa officinalis)の抽出物を併用してなる抗菌性の高い低刺激化粧料に関する。
【0002】
【従来の技術】
従来、化粧水,乳液,クリーム等、水を含有する化粧料においては、製造時及び使用時における細菌,かび等の微生物の混入による変質を防止するため、種々の防腐防黴剤が使用されてきた。かかる防腐剤としては、イソプロピルメチルフェノール,パラオキシ安息香酸エステル,フェノキシエタノール,ヒノキチオール等のフェノール類、安息香酸及びその塩,サリチル酸及びその塩,デヒドロ酢酸及びその塩,ソルビン酸及びその塩などの酸類、塩化ベンザルコニウム,塩化ベンゼトニウム,塩化アルキルトリメチルアンモニウム等の第4級アンモニウム類、塩酸アルキルアミノエチルグリシン,塩化ステアリルヒドロキシエチルベタインナトリウム等の両性界面活性剤、感光素などが用いられている。
【0003】
しかし、上記の防腐防黴剤には皮膚に対する一次刺激性,感作性或いは光感作性の報告されているものが多く、安全性の面から化粧品原料基準において配合量が規制されており、実際に有効な抗菌活性を示す量を配合できないことが多い。さらに、皮膚に対して発赤,発疹,浮腫といった刺激或いは感作反応を示さなくても、化粧料を使用する際に、刺すような痛みやヒリヒリする感じ又はチクチクする感じといった不快感を与えることも知られている。また、化粧料の基剤や他の配合成分との相互作用により、充分な抗菌活性を示さない場合もある。
【0004】
例えば、イソプロピルメチルフェノール,パラオキシ安息香酸エステル,ソルビン酸等の油溶性防腐防黴剤は、高分子増粘剤や粉体を含む化粧料に配合した場合、吸着等により抗菌活性が低下する。また、界面活性剤を含有する化粧料においては、界面活性剤ミセルへの取り込みによりやはり抗菌活性の低下が見られる。かといって、充分な抗菌活性を期待して多量に配合すると、低温での結晶析出等、製品の安定性上の問題が生じる。
【0005】
また、安息香酸塩,サリチル酸塩,デヒドロ酢酸塩等の水溶性防腐剤は、化粧料のpHが弱酸性でないと有効ではなく、酸性下にて使用する場合であっても、酸性が強くなるに従い水に対する溶解度が低下し、結晶の析出をきたすことがある。
【0006】
さらに、第4級アンモニウム類や両性界面活性剤については、皮膚刺激性,眼粘膜刺激性が認められたり、発泡しやすい,酸性側で抗菌活性が低下する,陰イオン性物質との相互作用などの実使用上の問題がある。
【0007】
【発明が解決しようとする課題】
従って、本発明においては、化粧料基剤や他の配合成分により抗菌活性が低下することなく有効な抗菌作用を示し、且つ可能な限り防腐防黴剤の配合量を少なくして、皮膚に対し一次刺激性や感作性を示さないだけではなく、化粧料使用時の刺すような痛みやヒリヒリ感,チクチク感といった不快感をも与えない化粧料を得ることを目的とした。
【0008】
【課題を解決するための手段】
上記課題を解決するため、安定性が高く、皮膚に対する刺激性の低い防腐防黴系を検討した結果、多価アルコール及び多価アルコールのアルキルエーテルより選んだ1種又は2種以上と、メリッサ(Melissa officinalis)の抽出物を併用して配合することにより、相乗的に抗菌活性が向上するばかりか、皮膚に対する刺激性や不快感が著しく低減することを見出だし、本発明を完成するに至った。
【0009】
【発明の実施の形態】
本発明においては、通常化粧料原料として使用される多価アルコールであれば用い得るが、特に分子内に4個以下の水酸基を有するものが、相乗的な抗菌活性を得る上で好ましい。例えば、エチレングリコール,ジエチレングリコール,トリエチレングリコール,プロピレングリコール,ジプロピレングリコール,1,3-ブチレングリコール,3-メチル-1,3-ブタンジオール(イソプロピレングリコール),ヘキシレングリコール,グリセリン,ジグリセリンなどが例示され、これらより、1種又は2種以上を選択して用いる。
【0010】
また、本発明において用いる多価アルコールのアルキルエーテルとしては、グリコール類又はグリセリンのアルキルエーテルが好適に使用でき、とくに、エチレングリコールモノメチルエーテル,エチレングリコールモノエチルエーテル(エチルエセロソルブ),エチレングリコールモノブチルエーテル(ブチルセロソルブ),エチレングリコールジメチルエーテル,ジエチレングリコールモノメチルエーテル(メチルカルビトール),ジエチレングリコールモノエチルエーテル(エチルカルビトール),ジエチレングリコールモノブチルエーテル,ジエチレングリコールジメチルエーテル,ジエチレングリコールジエチルエーテル,プロピレングリコールモノメチルエーテル,プロピレングリコールモノエチルエーテル,プロピレングリコールモノイソプロピルエーテル,ジプロピレングリコールモノメチルエーテル,ジプロピレングリコールモノエチルエーテル,グリセリルモノパルミチルエーテル(キミルアルコール),グリセリルモノステアリルエーテル(バチルアルコール),グリセリルモノオレイルエーテル(セラキルアルコール)等が好ましいものとして例示され、これらより1種又は2種以上を選択して用いる。
【0011】
これら多価アルコール又は多価アルコールのアルキルエーテルは、単独では5、0重量%以上で抗菌活性を示すが、化粧料のような複雑な系に添加した場合には、十分な抗菌作用が認められないことが多い。しかし、本発明においては相乗的な抗菌活性の増強が認められ、5.0〜10.0重量%程度の配合で十分な抗菌作用を示す。
【0012】
本発明において、多価アルコール又は多価アルコールのアルキルエーテルと併用するメリッサ(Melissa officinalis)は、シソ科の多年生の植物で、柑橘類のレモンのような香りがすることから、古くからハーブとして利用されている。このメリッサについてはすでに、チロシナーゼ活性阻害作用を有することを見出だし、これを配合した美白化粧料を開示している(特開平6−199647)。また、最近この抽出物がヒアルロニダーゼ活性阻害作用を有することが知られてきた。
【0013】
本発明に使用されるメリッサ抽出物は、メリッサの全草又はそれらの葉、茎、根、種子及び花のうち何れかを単独で、あるいは2種以上を組み合わせて用いる。また、生のまま若しくは乾燥した状態で抽出することができる。
【0014】
抽出溶媒としても特に限定されないが、水、エタノール,メタノール,1,3−ブチレングリコール,グリセリン,ジグリセリン,ポリグリセリン,イソプロピルアルコール等のアルコール類、アセトン,エーテル,テトラヒドロフラン等の有機溶媒等が例示され、これらを単独で又は2種以上を混合して用いることができる。また、抽出効率を高めるために界面活性剤を添加してもよい。これらの抽出溶媒の中でも、エタノール,1,3-ブチレングリコール及びこれらの水溶液等の極性溶媒を用いた場合特に有効な抗菌活性が得られる。抽出の際のメリッサと溶媒との比率は特に限定されるものではないが、メリッサ1に対して溶媒2〜1000重量倍、特に抽出操作、効率の点で5〜100重量倍が好ましい。
【0015】
さらに、抽出方法としては、室温,冷却又は加温した状態で含浸させて抽出する方法、水蒸気蒸留等の蒸留法を用いて抽出する方法、生のメリッサから圧搾して抽出物を得る圧搾法等が例示され、これらの方法を単独で又は2種以上を組み合わせて抽出を行う。
【0016】
また、このようにして得られたメリッサ抽出物は、抽出物をそのまま用いることもでき、また防腐防黴作用を失わない範囲内で脱臭,精製等の操作を加えてから配合することもでき、さらにはカラムクロマトグラフィー等を用いて分画物としてもよい。さらに、これらの抽出物や脱臭,精製物、分画物は、これらから溶媒を除去することによって乾燥物とすることもでき、さらにアルコールなどの溶媒に可溶化した形態、或いは乳剤の形態で提供することができる。化粧料への配合量は、0.01〜10重量%程度の低濃度で充分である。
【0017】
本発明にかかる化粧料としては、クリーム,軟膏,ローション,乳液,固形状,散剤など任意の剤型とすることができ、化粧水,乳液,美容液,保湿クリーム等の基礎化粧料、日焼け止めクリーム,日焼け止めローション,日焼けオイル,カーマインローション等のサンケア商品、ファンデーション,アイライナー,マスカラ,アイカラー,チークカラー,口紅などのメイクアップ化粧料、洗顔料,ボディーシャンプー,ヘアシャンプー等の洗浄料、リンス,トリートメント,ヘアクリーム,ヘアオイル,整髪剤などの毛髪用化粧料、香水、防臭制汗剤等の形態で提供することができる。
【0018】
その際、本発明の効果を損なわない範囲内で、化粧料に一般的に用いられる各種成分、例えば、アボカド油,パーム油,ピーナッツ油,コメヌカ油,ホホバ油,オレンジラフィー油,マカデミアナッツ油,スクワラン,月見草油,セサミ油,サンフラワー油,サフラワー油,キャローラ油,カルナウバワックス,パラフィンワックス,ラノリン,リンゴ酸ジイソステアリル,イソステアリルアルコール,流動パラフィン等の油分、コラーゲン,ヒアルロン酸等の保湿剤、ビタミンA油,レチノール,酢酸レチノール等のビタミンA類、リボフラビン,酪酸リボフラビン等のビタミンB2類、塩酸ピリドキシン等のビタミンB6類、L-アスコルビン酸,L-アスコルビルリン酸マグネシウム,L-アスコルビン酸ナトリウム等のビタミンC類、パントテン酸カルシウム,D-パントテニルアルコール,パントテニルエチルエーテル,アセチルパントテニルエチルエーテル等のパントテン酸類、エルゴカルシフェロール,コレカルシフェロール等のビタミンD類、ニコチン酸,ニコチン酸アミド,ニコチン酸ベンジル等のニコチン酸類、α-トコフェロール,酢酸トコフェロール等のビタミンE類、ビタミンP、ビオチン等のビタミン類、2-ヒドロキシ-4-メトキシベンゾフェノン,2-ヒドロキシ-4-メトキシベンゾフェノン-5-スルホン酸,2-ヒドロキシ-4-メトキシベンゾフェノン-5-スルホン酸ナトリウム等のベンゾフェノン誘導体、パラアミノ安息香酸,パラアミノ安息香酸エチル,パラジメチルアミノ安息香酸オクチル等のパラアミノ安息香酸誘導体、パラメトキシ桂皮酸-2-エチルヘキシル,ジパラメトキシ桂皮酸モノ-2-エチルヘキサン酸グリセリル等のメトキシ桂皮酸誘導体類、サリチル酸オクチル,サリチル酸ミリスチル等のサリチル酸誘導体、ウロカニン酸、4-tert-ブチル-4'-メトキシジベンゾイルメタン、2-(2'-ヒドロキシ-5'-メチルフェニル)ベンゾトリアゾール等の紫外線吸収剤、グアガム,ローカストビーンガム,カラギーナン,クインスシード,ペクチン,マンナン等の植物系天然多糖類、キサンタンガム,デキストラン,カードラン,ヒアルロン酸等の微生物系天然多糖類、ゼラチン,カゼイン,アルブミン,コラーゲン等の動物系高分子、メチルセルロース,エチルセルロース,ヒドロキシエチルセルロース,ヒドロキシプロピルセルロース,カルボキシメチルセルロース等のセルロース系半合成高分子、可溶性デンプン,カルボキシメチルデンプン,メチルデンプン等のデンプン系半合成高分子、アルギン酸プロピレングリコールエステル,アルギン酸塩等のアルギン酸系半合成高分子、ポリビニルアルコール,ポリビニルピロリドン,カルボキシビニルポリマー,ポリアクリル酸ナトリウム,ポリエチレンオキサイド等の合成高分子、ベントナイト,ラポナイト,コロイダルアルミナ等の無機物系高分子等の水溶性高分子、ジブチルヒドロキシトルエン,ブチルヒドロキシアニソール,没食子酸エステル等の酸化防止剤、高級脂肪酸石鹸,アルキル硫酸エステル塩,ポリオキシエチレンアルキルエーテル硫酸塩,アシルメチルタウリン塩,アルキルエーテルリン酸エステル塩,アシルアミノ酸塩等のアニオン界面活性剤、塩化アルキルトリメチルアンモニウム,塩化ジアルキルジメチルアンモニウム,塩化ベンザルコニウム等のカチオン界面活性剤、アルキルジメチルアミノ酢酸ベタイン,アルキルアミドジメチルアミノ酢酸ベタイン,2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタインなどの両性界面活性剤、ポリオキシエチレンアルキルエーテル,ポリオキシエチレンアルキルフェニルエーテル,ポリオキシエチレンポリオキシプロピレングリコール,ポリオキシエチレンポリオキシプロピレンアルキルエーテル,ポリオキシアルキレン脂肪酸グリセリンエステル,ポリオキシアルキレンソルビタンエステル,ソルビット系オリゴマー型テトラエステル,ソルビット系オリゴマー型ヘキサエステル,ポリエチレングリコールエステル,グリセリン脂肪酸エステル,ソルビタン脂肪酸エステル,ショ糖脂肪酸エステル,アルキロールアミド,脂肪酸アミド等のノニオン界面活性剤、エチレンジアミン四酢酸ナトリウム塩,ポリリン酸ナトリウム,クエン酸,メタリン酸ナトリウム,コハク酸,グルコン酸等の金属イオン封鎖剤、胎盤抽出物,ソウハクヒエキス,グルタチオン,コウジ酸及びその誘導体類,ハイドロキノン配糖体等のハイドロキノン及びその誘導体類等の美白剤、グリチルリチン酸,グリチルレチン酸,アラントイン,アズレン,ヒドロコルチゾン,ε-アミノカプロン酸等の抗炎症剤、アラントインヒドロキシアルミニウム,塩化アルミニウム,タンニン酸,クエン酸,乳酸等の収れん剤、メントール,カンフル等の清涼化剤、塩酸ジフェンヒドラミン,マレイン酸クロルフェニラミン等の抗ヒスタミン剤、エストラジオール,エストロン,エチニルエストラジオール等の皮脂抑制剤、サリチル酸,レゾルシン等の角質剥離・溶解剤、α−ヒドロキシ酸類等が配合できる。
【0019】
【実施例】
さらに本発明の特徴について、実施例により詳細に説明する。まず、本発明で使用するメリッサ抽出物の製造方法を次に示す。
【0020】
[メリッサ抽出物調製方法]
メリッサの全草30gを2倍量の50%エタノール,1,3-ブチレングリコール等の溶媒に1週間浸漬した後濾過して植物抽出物を得る。これを凍結乾燥し、さらに0.2mg/ml水溶液を調製し、メリッサ抽出物とした。
【0021】
[実施例1]化粧水
(1)エタノール 7.0(重量%)
(2)1,3-ブチレングリコール 10.0
(3)グリセリン 2.0
(4)ポリオキシエチレン硬化ヒマシ油 0.6
(5)メリッサ抽出物 1.0
(6)香料 0.06
(7)精製水 79.34
製法:(1)〜(6)の各成分を順次(7)に添加し、均一に混合して調製する。
【0022】
[実施例2]乳液
(1)スクワラン 4.0(重量%)
(2)トリ-2-エチルヘキサン酸グリセリル 2.0
(3)2-エチルヘキサン酸セチル 3.0
(4)セタノール 0.6
(5)ステアリルアルコール 0.4
(6)ソルビタンモノステアリン酸エステル 1.2
(7)1,3-ブチレングリコール 6.0
(8)ジプロピレングリコール 4.0
(9)ポリオキシエチレン(20EO)ソルビタン 0.8
モノステアリン酸エステル
(10)精製水 75.9
(11)メリッサ抽出物 2.0
(12)香料 0.1
製法:まず、(1)〜(6)の油相を混合し、加熱融解して75℃に保つ。一方(7)〜(10)の水相を混合し、加熱溶解して75℃とし、これに前記油相を攪拌しながら添加して乳化する。冷却後40℃にて(11),(12)を添加,混合する。
【0023】
[実施例3]クリーム
(1)ステアリルアルコール 6.0(重量%)
(2)ステアリン酸 2.0
(3)水素添加ラノリン 4.0
(4)スクワラン 9.0
(5)オクチルドデカノール 10.0
(6)ポリオキシエチレン(25EO)セチルアルコールエーテル 3.0
(7)グリセリルモノステアリン酸エステル 2.0
(8)1,3-ブチレングリコール 6.0
(9)ジエチレングリコールモノエチルエーテル 4.0
(10)精製水 50.9
(11)メリッサ抽出物 3.0
(12)香料 0.1
製法:(1)〜(7)の油相成分を混合,加熱して75℃とする。一方、(8)〜(10)の水相成分を混合,加熱して75℃とし、これに前記油相を添加して乳化し、冷却後40℃にて(11),(12)を添加する。
【0024】
[実施例4]メイクアップベースクリーム
(1)ステアリン酸 12.0(重量%)
(2)セタノール 2.0
(3)自己乳化型グリセリルモノステアリン酸エステル 2.0
(4)プロピレングリコール 10.0
(5)グリセリン 3.0
(6)水酸化カリウム 0.3
(7)精製水 67.6
(8)メリッサ抽出物 1.5
(9)香料 0.1
(10)二酸化チタン 1.0
(11)ベンガラ 0.1
(12)黄酸化鉄 0.4
製法:(10)〜(12)を(4)で混練し、これを(5)〜(7)の水相に添加,混合し、70℃に加熱する。一方、(1)〜(3)の油相成分を混合,加熱して70℃とし、これを前記水相に攪拌しながら添加して乳化する。乳化後冷却して40℃にて(8),(9)を添加する。
【0025】
[実施例5]乳液状ファンデーション
(1)ステアリン酸 2.4(重量%)
(2)モノステアリン酸プロピレングリコール 2.0
(3)セトステアリルアルコール 0.2
(4)液状ラノリン 2.0
(5)流動パラフィン 3.0
(6)ミリスチン酸イソプロピル 8.5
(7)グリセリルモノステアリルエーテル 3.5
(8)カルボキシメチルセルロースナトリウム 0.2
(9)ベントナイト 0.5
(10)イソプレングリコール 4.0
(11)トリエタノールアミン 1.1
(12)精製水 53.5
(13)メリッサ抽出物 1.0
(14)香料 0.1
(15)酸化チタン 8.0
(16)タルク 4.0
(17)ベンガラ 3.0
(18)黄酸化鉄 2.5
(19)黒酸化鉄 0.5
製法:(15)〜(19)の顔料を混合後、粉砕機により粉砕する。(12)を70℃に加熱し、(9)を加えてよく膨潤させ、これにあらかじめ(8)を(10)に分散させたものを加え、さらに(11)を添加し、溶解させる。(1)〜(7)の油相は混合し、加熱融解して80℃とする。前記顔料を水相に攪拌しながら加え、コロイドミルを通して75℃とし、前記油相を攪拌しながら加えて乳化し、冷却後40℃にて(13),(14)を添加する。
【0026】
[実施例6]クリーム状ファンデーション
(1)ステアリン酸 5.0(重量%)
(2)親油型グリセリルモノステアリン酸エステル 2.5
(3)モノラウリン酸プロピレングリコール 3.0
(4)セトステアリルアルコール 1.0
(5)流動パラフィン 7.0
(6)ミリスチン酸イソプロピル 8.0
(7)ジグリセリン 3.0
(8)トリエチレングリコール 2.0
(9)トリエタノールアミン 1.2
(10)精製水 44.2
(11)メリッサ抽出物 2.0
(12)香料 0.1
(13)酸化チタン 8.0
(14)カオリン 5.0
(15)タルク 2.0
(16)ベントナイト 1.0
(17)ベンガラ 2.6
(18)黄酸化鉄 2.1
(19)黒酸化鉄 0.3
製法:(13)〜(19)の顔料を混合後、粉砕機により粉砕する。(7)〜(10)を混合,溶解させ、加熱する。(1)〜(6)の油相は混合し、加熱溶解して80℃とする。前記顔料を水相に攪拌しながら加え、コロイドミルを通して75℃とし、前記油相を攪拌しながら加えて乳化し、冷却後40℃にて(11),(12)を添加する。
【0027】
[実施例7]乳化型アイカラー
(1)ステアリン酸 8.0(重量%)
(2)白色ワセリン 15.0
(3)パルミチン酸イソプロピル 5.0
(4)ラノリン 5.0
(5)1,3-ブチレングリコール 5.0
(6)ヘキシレングリコール 5.0
(7)トリエタノールアミン 2.0
(8)精製水 50.83
(9)メリッサ抽出物 2.5
(10)香料 0.15
(11)赤色221号 0.02
(12)群青 1.50
製法:(5)〜(8)の水相を混合,溶解して加熱し、これにあらかじめ混合,粉砕した(11),(12)を添加,分散し、75℃に加熱する。これにあらかじめ混合,加熱して均一とした(1)〜(4)を攪拌しながら添加して乳化し、冷却後(9)及び(10)を添加,混合する。
【0028】
[実施例8]乳化型チークカラー
製法:(11)〜(13)の水相を混合,溶解して加熱し、これにあらかじめ混合,粉砕した(16),(17)を添加,分散し、75℃に加熱する。これにあらかじめ混合,加熱して均一とした(1)〜(10)を攪拌しながら添加して乳化し、冷却後(14),(15)を添加,混合する。
【0029】
[実施例9]乳化型アイライナー
(1)ステアリン酸 3.5(重量%)
(2)ミツロウ 2.0
(3)カルナウバロウ 0.5
(4)マイクロクリスタリンワックス 5.0
(5)1,3-ブチレングリコール 7.0
(6)エチレングリコールモノブチルエーテル 2.5
(7)トリエタノールアミン 1.5
(8)精製水 45.9
(9)メリッサ抽出物 2.0
(10)香料 0.1
(11)3.0重量%ベントナイト抽出物 20.0
(12)酸化チタン 8.0
(13)カーボンブラック 2.0
製法:(1)〜(4)の油相成分を混合・加熱して溶解させる。これに(5)〜(8)の水相を混合,加熱し、攪拌しながら加えて乳化する。次いで、この乳化物に(11)〜(13)を加え、コロイドミルを通して分散させた後冷却し、40℃にて(9),(10)を加える。
【0030】
[実施例10]水性懸濁型マスカラ
(1)50重量%酢酸ビニルエマルション 37.0(重量%)
(2)カルボキシメチルセルロースナトリウム 1.0
(3)1,3-ブチレングリコール 3.5
(4)エチレングリコールモノメチルエーテル 3.5
(5)メリッサ抽出物 3.0
(6)酸化チタン 8.0
(7)カーボンブラック 1.6
(8)ベンガラ 0.4
(9)精製水 42.0
製法;(9)に(2)〜(5)を添加して溶解させ、次いで(6)〜(8)を添加し、コロイドミルを通して分散させる。これに(1)を加え、均一に分散させる。
【0031】
[実施例11]クレンジングジェル
(1)グリセリン 15.0(重量%)
(2)1,3-ブチレングリコール 10.0
(3)無水ケイ酸 7.0
(4)ポリオキシエチレン(20EO)ラウリルエーテル 5.0
(5)ポリオキシエチレン(50EO)硬化ヒマシ油 2.5
(6)ジエチレングリコールモノエチルエーテル 5.0
(7)カルボキシビニルポリマー 0.5
(8)水酸化カリウム 0.45
(9)メリッサ抽出物 2.0
(10)香料 0.1
(11)精製水 52.45
製法;(3),(7)を(11)に添加し均一とした後、(1)及び(2)に(4)〜(6)を溶解させて加え、70℃に加熱して均一に溶解させる。次いで冷却して40℃にて(9),(10)を添加し、最後に(8)を加えて中和する。
【0032】
[実施例12]ヘアリンス
(1)セタノール 3.0(重量%)
(2)塩化ステアリルトリメチルアンモニウム 0.7
(3)シリコーン油 3.0
(4)ポリオキシエチレン(10EO)オレイルエーテル 1.0
(5)グリセリン 5.0
(6)メリッサ抽出物 1.5
(7)緑色3号1重量%水溶液 0.2
(8)香料 0.1
(9)精製水 85.5
製法;(9)に(5),(7)を加え、70℃に加熱する。一方(1)〜(4)を混合,溶解し、70℃に加熱する。この油相を攪拌しながら先に調製した水相に徐々に加えて予備乳化し、ホモミキサーを加えて均一とした後冷却し、40℃にて(6),(8)を添加する。
【0033】
[実施例13]ヘアトリートメント
(1)ポリオキシエチレン(30EO)ベへニルエーテル 4.0(重量%)
(2)自己乳化型グリセリルモノステアレート 6.0
(3)ミリスチン酸イソプロピル 5.0
(4)ヘキシルデカノール 5.0
(5)スクワラン 3.0
(6)精製ラノリン 3.0
(7)ステアリン酸 5.0
(8)ラウリルジメチルアミノ酢酸ベタイン 5.0
(9)グリセリン 10.0
(10)精製水 52.8
(11)香料 0.2
(12)メリッサ抽出物 1.0
製法:(1)〜(7)の油相成分を混合,加熱して80℃とする。一方、(8)〜(10)の水相成分を混合,加熱して85℃とし、これに前記油相を添加して乳化し、冷却後40℃にて(11)及び(12)を添加する。
【0034】
[実施例14]洗顔料
(1)ステアリン酸 10.0(重量%)
(2)パルミチン酸 10.0
(3)ミリスチン酸 12.0
(4)ラウリン酸 4.0
(5)オレイルアルコール 1.5
(6)ラノリンアルコール 1.0
(7)水酸化カリウム 6.0
(8)精製水 44.4
(9)1,3-ブチレングリコール 10.0
(10)香料 0.1
(11)メリッサ抽出物 1.0
製法:(1)〜(6)の油相及び(7)〜(9)の水相をそれぞれ75℃に混合加熱溶解した後、油相に水相を加えてケン化する。冷却後40℃で(10)及び(11)を添加して混合する。
【0035】
[実施例15]ボディシャンプー
(1)ラウリン酸 5.0(重量%)
(2)ミリスチン酸 7.5
(3)ラウロイルジエタノールアミド 5.0
(4)グリセリン 20.0
(5)水酸化カリウム(10重量%水溶液) 3.0
(6)精製水 58.7
(7)メリッサ抽出物 0.5
(8)香料 0.3
製法:(1)〜(3)の油相及び(4)〜(6)の水相をそれぞれ75℃に混合加熱溶解した後、油相に水相を加えてケン化する。冷却後40℃で(7)及び(8)を添加して混合する。
【0036】
次に、上記の実施例1〜15について、抗菌活性,皮膚刺激性及び使用時の不快感について評価を行った。同時に表1に示す比較例についても同様に抗菌活性の評価を行った。
【0037】
【表1】
【0038】
(1)抗菌活性の評価 細菌として大腸菌(Escherichia coli),黄色ブドウ球菌(Staphylococcus aureus)及び緑濃菌(Pseudomonas aeruginosa)を、真菌としてカンジダ(Candida albicans)及び黒カビ(Aspergillus niger)を用い、試料1g当たり細菌は106個,真菌は105個を植菌し、37℃及び25℃でそれぞれ培養して、2週間後の生菌数を測定した。なお、抗菌活性は2週間後に、細菌については死滅した場合、真菌については生菌数が1/1000以下となった場合に合格であると判断した。なお抗菌力試験結果は、表2及び表3において合格したものを「○」、不合格のものを「×」として示した。
【0039】
【表2】
【0040】
【表3】
【0041】
表2において明らかなように、本発明の実施例においては、いずれも細菌及び真菌の双方に対して十分な抗菌活性が認められていた。これに対し表3に示した通り、メリッサ抽出物のみを含有する比較例2,5,7,9,11,13及び15においては、ほとんどの試験菌に対して抗菌活性が認められていなかった。また、多価アルコール又はそのアルキルエーテルのみを含有する比較例1,3,4,6,8,10,12及び14においても、一部又は全ての試験菌に対し合格基準を満たしていなかった。
【0042】
(2)皮膚刺激性の評価 各試料について、男性パネラー30名を用いて、48時間閉塞貼付試験を行い、表4に示す判定基準により評価し、30名の皮膚刺激指数の平均値を求めた。なお、実施例11〜実施例15については、1.0重量%水溶液を試験に用いた。
【0043】
【表4】
【0044】
(3)使用時の不快感の評価 女性パネラー20名を1群とし、各群に各試料をそれぞれ使用させ、塗布後30秒から1分間の間に感じる刺すような痛み,ヒリヒリ感,チクチク感といった不快感について評価させた。評価結果は、「非常に強く感じる;5点」,「やや強く感じる;4点」,「感じる;3点」,「少し感じる;2点」,「微妙に感じる;1点」,「感じない;0点」として評価し、20名の平均値にて示した。この際にも、実施例11〜実施例15については、1.0重量%水溶液を試験に用いた。以上の結果を表5にまとめて示した。
【0045】
【表5】
【0046】
表5において、本発明の実施例については、いずれにおいても皮膚刺激性は認められておらず、使用時の不快感も微妙に感じられる程度である。
【0047】
【発明の効果】
以上詳述したように、本発明により、抗菌作用が相乗的に強化され、しかも皮膚刺激性のみならず、使用時の刺すような痛み,ヒリヒリ感,チクチク感といった不快感もほとんど感じられない抗菌性化粧料を得ることができた。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a cosmetic that has excellent antibacterial properties, is stable against contamination with microorganisms such as bacteria and mold, and has low irritation to the skin. More specifically, one or more selected from polyhydric alcohols and alkyl ethers of polyhydric alcohols, and Melissa (Melissa officinalis) And an antibacterial hypoallergenic cosmetic composition.
[0002]
[Prior art]
Conventionally, in cosmetics containing water such as skin lotion, milky lotion, cream, etc., various antiseptic / antifungal agents have been used in order to prevent deterioration due to contamination with microorganisms such as bacteria and mold during production and use. It was. Such preservatives include phenols such as isopropylmethylphenol, p-hydroxybenzoate, phenoxyethanol, hinokitiol, benzoic acid and its salts, salicylic acid and its salts, dehydroacetic acid and its salts, acids such as sorbic acid and its salts, chloride Quaternary ammoniums such as benzalkonium chloride, benzethonium chloride and alkyltrimethylammonium chloride, amphoteric surfactants such as alkylaminoethylglycine hydrochloride and sodium stearylhydroxyethylbetaine, and photosensitizers are used.
[0003]
However, many of the above-mentioned antiseptic / antifungal agents have been reported for primary irritation, sensitization or photosensitization to the skin, and the amount of cosmetics is regulated in the cosmetic raw material standards from the viewpoint of safety. In many cases, the amount that actually shows effective antibacterial activity cannot be blended. Furthermore, even if the skin does not show irritation or sensitization such as redness, rash, or edema, it may cause discomfort such as stinging, tingling or tingling when using cosmetics. Are known. Moreover, sufficient antibacterial activity may not be shown by interaction with the base of cosmetics or another compounding component.
[0004]
For example, when an oil-soluble antiseptic and antifungal agent such as isopropylmethylphenol, paraoxybenzoic acid ester, and sorbic acid is blended in a cosmetic containing a polymer thickener or powder, the antibacterial activity decreases due to adsorption or the like. Moreover, in cosmetics containing a surfactant, a decrease in antibacterial activity is also observed due to incorporation into the surfactant micelle. However, if a large amount is added in anticipation of sufficient antibacterial activity, problems such as crystal precipitation at a low temperature will occur.
[0005]
Water-soluble preservatives such as benzoate, salicylate, and dehydroacetate are not effective unless the pH of the cosmetic is weakly acidic, and even when used under acidic conditions, The solubility in water may decrease, and crystals may be precipitated.
[0006]
In addition, for quaternary ammoniums and amphoteric surfactants, skin irritation and ocular mucosal irritation are observed, easy to foam, antibacterial activity decreases on the acidic side, interaction with anionic substances, etc. There is a problem in actual use.
[0007]
[Problems to be solved by the invention]
Therefore, in the present invention, the antibacterial activity is not reduced by the cosmetic base and other blending components, and effective antibacterial action is exhibited, and the blending amount of the antiseptic / antifungal agent is reduced as much as possible to the skin. The purpose of the present invention is to obtain a cosmetic that not only exhibits no primary irritation and sensitization, but also does not cause discomfort such as stinging pain, tingling, and tingling sensation when using the cosmetic.
[0008]
[Means for Solving the Problems]
In order to solve the above problems, as a result of studying antiseptic and antifungal systems having high stability and low irritation to the skin, one or more selected from polyhydric alcohols and alkyl ethers of polyhydric alcohols, and Melissa (Melissa officinalisIt was found that the combined use of the extract of) not only synergistically improves the antibacterial activity, but also significantly reduces irritation and discomfort to the skin, thereby completing the present invention.
[0009]
DETAILED DESCRIPTION OF THE INVENTION
In the present invention, any polyhydric alcohol that is usually used as a cosmetic raw material can be used. In particular, those having 4 or less hydroxyl groups in the molecule are preferred for obtaining synergistic antibacterial activity. For example, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, 3-methyl-1,3-butanediol (isopropylene glycol), hexylene glycol, glycerin, diglycerin, etc. From these, one type or two or more types are selected and used.
[0010]
In addition, as the alkyl ether of the polyhydric alcohol used in the present invention, glycols or alkyl ethers of glycerin can be preferably used, and in particular, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether (ethyl etherosolve), ethylene glycol monobutyl ether. (Butyl cellosolve), ethylene glycol dimethyl ether, diethylene glycol monomethyl ether (methyl carbitol), diethylene glycol monoethyl ether (ethyl carbitol), diethylene glycol monobutyl ether, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene Glico Preferred are rumonoisopropyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, glyceryl monopalmityl ether (chimyl alcohol), glyceryl monostearyl ether (batyl alcohol), glyceryl monooleyl ether (ceralkyl alcohol), etc. 1 type or 2 types or more are selected and used from these.
[0011]
These polyhydric alcohols or alkyl ethers of polyhydric alcohols alone exhibit antibacterial activity at 5, 0% by weight or more. However, when added to complex systems such as cosmetics, sufficient antibacterial activity is observed. Often not. However, in the present invention, a synergistic enhancement of antibacterial activity is observed, and a sufficient antibacterial action is exhibited with a blending of about 5.0 to 10.0% by weight.
[0012]
In the present invention, Melissa used together with polyhydric alcohol or alkyl ether of polyhydric alcohol (Melissa officinalis) Is a perennial plant belonging to the family Lamiaceae and has been used as an herb since ancient times because it smells like a citrus lemon. This melissa has already been found to have a tyrosinase activity inhibitory action, and a whitening cosmetic containing this is disclosed (Japanese Patent Laid-Open No. Hei 6-199647). Recently, it has been known that this extract has an inhibitory action on hyaluronidase activity.
[0013]
As the Melissa extract used in the present invention, all of Melissa's plants or their leaves, stems, roots, seeds and flowers are used alone or in combination of two or more. Further, it can be extracted in a raw state or in a dry state.
[0014]
Although it does not specifically limit as an extraction solvent, Organic solvents, such as water, ethanol, methanol, 1, 3- butylene glycol, glycerol, diglycerol, polyglycerol, isopropyl alcohol, etc., acetone, ether, tetrahydrofuran, etc. are illustrated. These can be used alone or in admixture of two or more. Further, a surfactant may be added to increase the extraction efficiency. Among these extraction solvents, particularly effective antibacterial activity is obtained when polar solvents such as ethanol, 1,3-butylene glycol, and aqueous solutions thereof are used. The ratio of the melissa and the solvent at the time of extraction is not particularly limited, but is preferably 2 to 1000 times by weight of the solvent with respect to Melissa 1 and particularly preferably 5 to 100 times by weight in terms of extraction operation and efficiency.
[0015]
Furthermore, as an extraction method, a method of impregnating and extracting in a cooled or heated state at room temperature, a method of extracting using a distillation method such as steam distillation, a pressing method of obtaining an extract by squeezing from raw Melissa, etc. And these methods are used alone or in combination of two or more.
[0016]
In addition, the Melissa extract thus obtained can be used as it is, or can be formulated after adding operations such as deodorization and purification within a range that does not lose the antiseptic and antifungal action, Furthermore, it is good also as a fraction using column chromatography etc. Furthermore, these extracts, deodorized products, purified products, and fractions can be made dry by removing the solvent from them, and are also provided in the form of solubilized in a solvent such as alcohol or in the form of an emulsion. can do. A low concentration of about 0.01 to 10% by weight is sufficient for the amount of the cosmetic.
[0017]
Cosmetics according to the present invention can be in any dosage form such as creams, ointments, lotions, emulsions, solids, powders, basic cosmetics such as skin lotions, emulsions, cosmetics, moisturizing creams, sunscreens Suncare products such as cream, sunscreen lotion, suntan oil, carmine lotion, makeup cosmetics such as foundation, eyeliner, mascara, eye color, teak color, lipstick, face wash, body shampoo, hair shampoo, etc. It can be provided in the form of rinsing, treatment, hair cream, hair oil, hair cosmetics such as hair conditioner, perfume, deodorant antiperspirant and the like.
[0018]
At this time, various components commonly used in cosmetics within the range not impairing the effects of the present invention, such as avocado oil, palm oil, peanut oil, rice bran oil, jojoba oil, orange luffy oil, macadamia nut oil, squalane. , Evening primrose oil, sesame oil, sunflower oil, safflower oil, carola oil, carnauba wax, paraffin wax, lanolin, diisostearyl malate, isostearyl alcohol, liquid paraffin oil, collagen, hyaluronic acid, etc. , Vitamin A oil, vitamin A such as retinol and retinol acetate, vitamin B such as riboflavin and riboflavin butyrate2, Vitamin B such as pyridoxine hydrochloride6Vitamins such as L-ascorbic acid, magnesium L-ascorbyl phosphate, sodium L-ascorbate, pantothenic acids such as calcium pantothenate, D-pantothenyl alcohol, pantothenyl ethyl ether, acetyl pantothenyl ethyl ether, Vitamin D such as ergocalciferol and cholecalciferol, nicotinic acid such as nicotinic acid, nicotinic acid amide and benzyl nicotinate, vitamin E such as α-tocopherol and tocopherol acetate, vitamins such as vitamin P and biotin, 2 Benzophenone derivatives such as 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid, 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid sodium salt, paraaminobenzoic acid, ethyl paraaminobenzoate, Pa Paraaminobenzoic acid derivatives such as octyl dimethylaminobenzoate, methoxycinnamic acid derivatives such as paramethoxycinnamic acid-2-ethylhexyl, diparamethoxycinnamic acid mono-2-ethylhexanoic acid glyceryl, salicylic acid derivatives such as octyl salicylate, myristyl salicylate, urocanin UV absorbers such as acid, 4-tert-butyl-4'-methoxydibenzoylmethane, 2- (2'-hydroxy-5'-methylphenyl) benzotriazole, guar gum, locust bean gum, carrageenan, quince seed, pectin , Plant natural polysaccharides such as mannan, microbial natural polysaccharides such as xanthan gum, dextran, curdlan, hyaluronic acid, animal polymers such as gelatin, casein, albumin and collagen, methylcellulose, ethylcellulose, hydroxyethylcellulose, Cellulose semi-synthetic polymers such as droxypropyl cellulose and carboxymethyl cellulose, starch-based semi-synthetic polymers such as soluble starch, carboxymethyl starch, and methyl starch, alginic acid-based semi-synthetic polymers such as alginic acid propylene glycol ester and alginate, Synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, sodium polyacrylate, polyethylene oxide, etc., water-soluble polymers such as inorganic polymers such as bentonite, laponite, colloidal alumina, dibutylhydroxytoluene, butylhydroxyanisole, Antioxidants such as gallic acid esters, higher fatty acid soaps, alkyl sulfate esters, polyoxyethylene alkyl ether sulfates, acylmethyl taurates, alkyls Anionic surfactants such as ether phosphate ester salts and acylamino acid salts, cationic surfactants such as alkyltrimethylammonium chloride, dialkyldimethylammonium chloride, benzalkonium chloride, alkyldimethylaminoacetic acid betaines, alkylamidodimethylaminoacetic acid betaines, Amphoteric surfactants such as 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene polyoxypropylene glycol, polyoxyethylene polyoxy Propylene alkyl ether, polyoxyalkylene fatty acid glycerin ester, polyoxyalkylene sorbitan ester, sorbite oligomer tetraester, sorbit Nonionic surfactants such as ligomer type hexaester, polyethylene glycol ester, glycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, alkylolamide, fatty acid amide, ethylenediaminetetraacetic acid sodium salt, sodium polyphosphate, citric acid, metaphosphoric acid Metal ion sequestering agents such as sodium, succinic acid and gluconic acid, placenta extract, Sahakuhi extract, glutathione, kojic acid and derivatives thereof, whitening agents such as hydroquinone and its derivatives such as hydroquinone glycosides, glycyrrhizic acid and glycyrrhetin Anti-inflammatory agents such as acid, allantoin, azulene, hydrocortisone, ε-aminocaproic acid, astringents such as allantoin hydroxyaluminum, aluminum chloride, tannic acid, citric acid, lactic acid, menthol, Can be blended with a refreshing agent such as Nufur, an antihistamine such as diphenhydramine hydrochloride, chlorpheniramine maleate, a sebum inhibitor such as estradiol, estrone, ethinylestradiol, a keratin exfoliating / dissolving agent such as salicylic acid and resorcin, and α-hydroxy acids .
[0019]
【Example】
Further, the features of the present invention will be described in detail with reference to examples. First, the manufacturing method of the Melissa extract used by this invention is shown next.
[0020]
[Melissa extract preparation method]
A plant extract is obtained by immersing 30 g of Melissa's whole plant in a solvent such as 50% ethanol, 1,3-butylene glycol and the like for one week, followed by filtration. This was freeze-dried, and a 0.2 mg / ml aqueous solution was further prepared to obtain a Melissa extract.
[0021]
[Example 1] Lotion
(1) Ethanol 7.0 (% by weight)
(2) 1,3-butylene glycol 10.0
(3) Glycerin 2.0
(4) Polyoxyethylene hydrogenated castor oil 0.6
(5) Melissa extract 1.0
(6) Perfume 0.06
(7) Purified water 79.34
Manufacturing method: Each component of (1) to (6) is added to (7) sequentially and mixed to prepare.
[0022]
[Example 2] Emulsion
(1) Squalane 4.0 (wt%)
(2) Glyceryl tri-2-ethylhexanoate 2.0
(3) Cetyl 2-ethylhexanoate 3.0
(4) Cetanol 0.6
(5) Stearyl alcohol 0.4
(6) Sorbitan monostearate ester 1.2
(7) 1,3-butylene glycol 6.0
(8) Dipropylene glycol 4.0
(9) Polyoxyethylene (20EO) sorbitan 0.8
Monostearic acid ester
(10) Purified water 75.9
(11) Melissa extract 2.0
(12) Fragrance 0.1
Production method: First, the oil phases (1) to (6) are mixed, heated and melted and kept at 75 ° C. On the other hand, the aqueous phases (7) to (10) are mixed, dissolved by heating to 75 ° C., and the oil phase is added to this while stirring to emulsify. Add and mix (11) and (12) at 40 ° C after cooling.
[0023]
[Example 3] Cream
(1) Stearyl alcohol 6.0 (% by weight)
(2) Stearic acid 2.0
(3) Hydrogenated lanolin 4.0
(4) Squalane 9.0
(5) Octyldodecanol 10.0
(6) Polyoxyethylene (25EO) cetyl alcohol ether 3.0
(7) Glyceryl monostearate ester 2.0
(8) 1,3-butylene glycol 6.0
(9) Diethylene glycol monoethyl ether 4.0
(10) Purified water 50.9
(11) Melissa extract 3.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (7) are mixed and heated to 75 ° C. On the other hand, the water phase components (8) to (10) are mixed and heated to 75 ° C., and the oil phase is added thereto to emulsify. After cooling, (11) and (12) are added at 40 ° C. To do.
[0024]
[Example 4] Makeup base cream
(1) Stearic acid 12.0 (wt%)
(2) Cetanol 2.0
(3) Self-emulsifying glyceryl monostearate 2.0
(4) Propylene glycol 10.0
(5) Glycerol 3.0
(6) Potassium hydroxide 0.3
(7) Purified water 67.6
(8) Melissa extract 1.5
(9) Fragrance 0.1
(10) Titanium dioxide 1.0
(11) Bengala 0.1
(12) Yellow iron oxide 0.4
Production method: (10) to (12) are kneaded in (4), added to the aqueous phase of (5) to (7), mixed and heated to 70 ° C. On the other hand, the oil phase components (1) to (3) are mixed and heated to 70 ° C. and added to the aqueous phase with stirring to emulsify. After emulsification, cool and add (8), (9) at 40 ° C.
[0025]
[Example 5] Emulsion foundation
(1) Stearic acid 2.4 (% by weight)
(2) Propylene glycol monostearate 2.0
(3) Cetostearyl alcohol 0.2
(4) Liquid lanolin 2.0
(5) Liquid paraffin 3.0
(6) Isopropyl myristate 8.5
(7) Glyceryl monostearyl ether 3.5
(8) Sodium carboxymethyl cellulose 0.2
(9) Bentonite 0.5
(10) Isoprene glycol 4.0
(11) Triethanolamine 1.1
(12) Purified water 53.5
(13) Melissa extract 1.0
(14) Fragrance 0.1
(15) Titanium oxide 8.0
(16) Talc 4.0
(17) Bengala 3.0
(18) Yellow iron oxide 2.5
(19) Black iron oxide 0.5
Production method: The pigments (15) to (19) are mixed and then pulverized by a pulverizer. (12) is heated to 70 ° C., (9) is added to swell well, (8) previously dispersed in (10) is added thereto, and (11) is further added and dissolved. The oil phases (1) to (7) are mixed and heated to melt to 80 ° C. The pigment is added to the aqueous phase with stirring, and the mixture is brought to 75 ° C. through a colloid mill. The oil phase is added with stirring to emulsify, and after cooling, (13) and (14) are added at 40 ° C.
[0026]
[Example 6] Creamy foundation
(1) Stearic acid 5.0 (wt%)
(2) Lipophilic glyceryl monostearate 2.5
(3) Propylene glycol monolaurate 3.0
(4) cetostearyl alcohol 1.0
(5) Liquid paraffin 7.0
(6) Isopropyl myristate 8.0
(7) Diglycerin 3.0
(8) Triethylene glycol 2.0
(9) Triethanolamine 1.2
(10) Purified water 44.2
(11) Melissa extract 2.0
(12) Fragrance 0.1
(13) Titanium oxide 8.0
(14) Kaolin 5.0
(15) Talc 2.0
(16) Bentonite 1.0
(17) Bengala 2.6
(18) Yellow iron oxide 2.1
(19) Black iron oxide 0.3
Production method: The pigments (13) to (19) are mixed and then pulverized by a pulverizer. (7) to (10) are mixed, dissolved, and heated. The oil phases (1) to (6) are mixed and dissolved by heating to 80 ° C. The pigment is added to the aqueous phase with stirring, the temperature is adjusted to 75 ° C. through a colloid mill, the oil phase is added with stirring to emulsify, and after cooling, (11) and (12) are added at 40 ° C.
[0027]
[Example 7] Emulsifying eye color
(1) Stearic acid 8.0 (wt%)
(2) White petrolatum 15.0
(3) Isopropyl palmitate 5.0
(4) Lanolin 5.0
(5) 1,3-butylene glycol 5.0
(6) Hexylene glycol 5.0
(7) Triethanolamine 2.0
(8) Purified water 50.83
(9) Melissa extract 2.5
(10) Fragrance 0.15
(11) Red No. 221 0.02
(12) Ultramarine 1.50
Production method: The aqueous phases (5) to (8) are mixed, dissolved and heated, and (11) and (12) previously mixed and pulverized are added and dispersed therein, and heated to 75 ° C. Add and emulsify (1) to (4), which has been mixed and heated in advance, with stirring, and add (9) and (10) after cooling.
[0028]
[Example 8] Emulsion type cheek color
Production method: The aqueous phases (11) to (13) are mixed, dissolved and heated, and (16) and (17) previously mixed and pulverized are added, dispersed, and heated to 75 ° C. Add (1) to (10), which has been mixed and heated in advance, to this while stirring and emulsify, and after cooling, add and mix (14) and (15).
[0029]
[Example 9] Emulsifying eyeliner
(1) Stearic acid 3.5 (wt%)
(2) Beeswax 2.0
(3) Carnauba 0.5
(4) Microcrystalline wax 5.0
(5) 1,3-butylene glycol 7.0
(6) Ethylene glycol monobutyl ether 2.5
(7) Triethanolamine 1.5
(8) Purified water 45.9
(9) Melissa extract 2.0
(10) Fragrance 0.1
(11) 3.0 wt% bentonite extract 20.0
(12) Titanium oxide 8.0
(13) Carbon black 2.0
Production method: The oil phase components (1) to (4) are mixed and heated to be dissolved. To this, the aqueous phases (5) to (8) are mixed, heated, added with stirring and emulsified. Next, (11) to (13) are added to the emulsion, dispersed through a colloid mill, cooled, and (9) and (10) are added at 40 ° C.
[0030]
[Example 10] Aqueous suspension type mascara
(1) 50 wt% vinyl acetate emulsion 37.0 (wt%)
(2) Carboxymethylcellulose sodium 1.0
(3) 1,3-butylene glycol 3.5
(4) Ethylene glycol monomethyl ether 3.5
(5) Melissa extract 3.0
(6) Titanium oxide 8.0
(7) Carbon black 1.6
(8) Bengala 0.4
(9) Purified water 42.0
Production method: (2) to (5) are added and dissolved in (9), and then (6) to (8) are added and dispersed through a colloid mill. Add (1) to this and disperse uniformly.
[0031]
[Example 11] Cleansing Gel
(1) Glycerin 15.0 (wt%)
(2) 1,3-butylene glycol 10.0
(3) Silicic anhydride 7.0
(4) Polyoxyethylene (20EO) lauryl ether 5.0
(5) Polyoxyethylene (50EO) hydrogenated castor oil 2.5
(6) Diethylene glycol monoethyl ether 5.0
(7) Carboxyvinyl polymer 0.5
(8) Potassium hydroxide 0.45
(9) Melissa extract 2.0
(10) Fragrance 0.1
(11) Purified water 52.45
Manufacturing method: Add (3) and (7) to (11) to make uniform, then add (4) to (6) dissolved in (1) and (2), and heat to 70 ° C to make uniform Dissolve. Next, the mixture is cooled, (9) and (10) are added at 40 ° C, and finally (8) is added to neutralize.
[0032]
[Example 12] Hair rinse
(1) Cetanol 3.0 (wt%)
(2) Stearyltrimethylammonium chloride 0.7
(3) Silicone oil 3.0
(4) Polyoxyethylene (10EO) oleyl ether 1.0
(5) Glycerin 5.0
(6) Melissa extract 1.5
(7) Green No. 3 1 wt% aqueous solution 0.2
(8) Fragrance 0.1
(9) Purified water 85.5
Production method: Add (5) and (7) to (9) and heat to 70 ° C. On the other hand, (1) to (4) are mixed and dissolved and heated to 70 ° C. The oil phase is gradually added to the previously prepared aqueous phase with stirring, pre-emulsified, homogenized with a homomixer, cooled, and (6) and (8) are added at 40 ° C.
[0033]
[Example 13] Hair treatment
(1) Polyoxyethylene (30EO) behenyl ether 4.0 (wt%)
(2) Self-emulsifying glyceryl monostearate 6.0
(3) Isopropyl myristate 5.0
(4) Hexyldecanol 5.0
(5) Squalane 3.0
(6) Purified lanolin 3.0
(7) Stearic acid 5.0
(8) Lauryldimethylaminoacetic acid betaine 5.0
(9) Glycerin 10.0
(10) Purified water 52.8
(11) Fragrance 0.2
(12) Melissa extract 1.0
Production method: The oil phase components (1) to (7) are mixed and heated to 80 ° C. On the other hand, the water phase components (8) to (10) are mixed and heated to 85 ° C., and the oil phase is added and emulsified, and after cooling, (11) and (12) are added at 40 ° C. To do.
[0034]
[Example 14] Face wash
(1) Stearic acid 10.0 (wt%)
(2) Palmitic acid 10.0
(3) Myristic acid 12.0
(4) Lauric acid 4.0
(5) Oleyl alcohol 1.5
(6) Lanolin alcohol 1.0
(7) Potassium hydroxide 6.0
(8) Purified water 44.4
(9) 1,3-Butylene glycol 10.0
(10) Fragrance 0.1
(11) Melissa extract 1.0
Production method: The oil phases (1) to (6) and the water phases (7) to (9) are mixed and dissolved at 75 ° C., respectively, and then the water phase is added to the oil phase to saponify. After cooling, add (10) and (11) at 40 ° C. and mix.
[0035]
[Example 15] Body shampoo
(1) Lauric acid 5.0 (wt%)
(2) Myristic acid 7.5
(3) Lauroyl diethanolamide 5.0
(4) Glycerin 20.0
(5) Potassium hydroxide (10% by weight aqueous solution) 3.0
(6) Purified water 58.7
(7) Melissa extract 0.5
(8) Fragrance 0.3
Production method: The oil phases (1) to (3) and the water phases (4) to (6) are mixed and dissolved at 75 ° C. respectively, and then the water phase is added to the oil phase to saponify. After cooling, add (7) and (8) at 40 ° C. and mix.
[0036]
Next, the above Examples 1 to 15 were evaluated for antibacterial activity, skin irritation, and discomfort during use. At the same time, the comparative examples shown in Table 1 were similarly evaluated for antibacterial activity.
[0037]
[Table 1]
[0038]
(1) Evaluation of antibacterial activityEscherichia coli),Staphylococcus aureus(Staphylococcus aureus) And green bacteria (Pseudomonas aeruginosa) As Candida (Candida albicans) And black mold (Aspergillus niger) And 10 bacteria per gram of sample.610 fungiFiveThe cells were inoculated and cultured at 37 ° C. and 25 ° C., respectively, and the viable cell count after 2 weeks was measured. The antibacterial activity was judged to pass after 2 weeks, when the bacteria were killed, or when the number of viable fungi was 1/1000 or less. The antibacterial activity test results in Table 2 and Table 3 are shown as “◯”, and those rejected as “x”.
[0039]
[Table 2]
[0040]
[Table 3]
[0041]
As is clear from Table 2, in the examples of the present invention, sufficient antibacterial activity was recognized against both bacteria and fungi. On the other hand, as shown in Table 3, in Comparative Examples 2, 5, 7, 9, 11, 13, and 15 containing only Melissa extract, antibacterial activity was not recognized against most test bacteria. . In Comparative Examples 1, 3, 4, 6, 8, 10, 12 and 14 containing only a polyhydric alcohol or an alkyl ether thereof, the acceptance criteria were not satisfied for some or all of the test bacteria.
[0042]
(2) Evaluation of skin irritation For each sample, 30 male panelists were subjected to a 48-hour occlusion patch test and evaluated according to the criteria shown in Table 4, and the average value of 30 skin irritation indices was obtained. . In addition, about Example 11- Example 15, 1.0 weight% aqueous solution was used for the test.
[0043]
[Table 4]
[0044]
(3) Evaluation of discomfort during use Twenty female panelists are grouped into each group, and each group uses each sample, and stab pain, tingling, and tingling sensations are felt between 30 seconds and 1 minute after application. Such discomfort was evaluated. The evaluation results are: “I feel very strong; 5 points”, “I feel a little strongly; 4 points”, “I feel; 3 points”, “I feel a little; 2 points”, “I feel subtle; 1 point”, “I don't feel” ; 0 points ", and the average value of 20 people was shown. Also in this case, for Examples 11 to 15, a 1.0 wt% aqueous solution was used for the test. The above results are summarized in Table 5.
[0045]
[Table 5]
[0046]
In Table 5, no skin irritation was observed in any of the examples of the present invention, and the discomfort during use was slightly felt.
[0047]
【The invention's effect】
As described above in detail, according to the present invention, the antibacterial action is synergistically enhanced, and not only the skin irritation but also the discomfort such as stinging pain, tingling and tingling sensation during use is hardly felt. Sex cosmetics could be obtained.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP01751297A JP3757368B2 (en) | 1997-01-14 | 1997-01-14 | Antibacterial hypoallergenic cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP01751297A JP3757368B2 (en) | 1997-01-14 | 1997-01-14 | Antibacterial hypoallergenic cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10194915A JPH10194915A (en) | 1998-07-28 |
| JP3757368B2 true JP3757368B2 (en) | 2006-03-22 |
Family
ID=11946030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP01751297A Expired - Fee Related JP3757368B2 (en) | 1997-01-14 | 1997-01-14 | Antibacterial hypoallergenic cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3757368B2 (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2886549B2 (en) * | 1989-05-18 | 1999-04-26 | ポーラ化成工業株式会社 | Antibacterial agent manufacturing method |
| JPH04305512A (en) * | 1991-03-29 | 1992-10-28 | Shiseido Co Ltd | External preparation for skin |
| JP3093353B2 (en) * | 1991-08-12 | 2000-10-03 | 株式会社資生堂 | External preparation for skin |
| JP3260875B2 (en) * | 1992-12-09 | 2002-02-25 | 有限会社野々川商事 | Cosmetics |
| JPH06247831A (en) * | 1993-02-25 | 1994-09-06 | Mandamu:Kk | Cosmetic for hair of head |
| JP3195684B2 (en) * | 1993-03-01 | 2001-08-06 | 丸善製薬株式会社 | Skin cosmetics |
| JPH07330505A (en) * | 1994-06-08 | 1995-12-19 | Masato Suzuki | Antimicrobial composition |
| JPH08119869A (en) * | 1994-10-26 | 1996-05-14 | Mikimoto Pharmaceut Co Ltd | Active oxygen suppressor |
| JPH08143430A (en) * | 1994-11-17 | 1996-06-04 | Mandamu:Kk | Scalp treating agent |
| JP3630384B2 (en) * | 1996-12-20 | 2005-03-16 | 株式会社ノエビア | Antibacterial hypoallergenic cosmetic |
-
1997
- 1997-01-14 JP JP01751297A patent/JP3757368B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10194915A (en) | 1998-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101217382B1 (en) | EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE | |
| KR20220068226A (en) | Cosmetic or dermatological composition for removing and/or cleansing makeup comprising succinic acid for preventing, reducing or eliminating skin imperfections, treating skin disorders and preventing, treating and combating hyperseborrheic conditions of the scalp | |
| JP3615894B2 (en) | Antibacterial hypoallergenic cosmetic | |
| JP3758794B2 (en) | Collagen production promoter and anti-aging skin external preparation containing the same | |
| JP3601875B2 (en) | Cosmetics | |
| JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
| JP2002003358A (en) | Skin care preparation | |
| JPH09221410A (en) | Antiaging skin external preparation | |
| JP4136203B2 (en) | Skin preparation for external use | |
| JP3630384B2 (en) | Antibacterial hypoallergenic cosmetic | |
| JPH0995432A (en) | Preparation for external use for skin | |
| JPH11255612A (en) | Antibacterial agent and antibacterial composition | |
| JP3757368B2 (en) | Antibacterial hypoallergenic cosmetic | |
| JPH10203954A (en) | Antimicrobial low-irritating cosmetic | |
| JP3573883B2 (en) | Antibacterial hypoallergenic cosmetics | |
| JPH10194917A (en) | Antimicrobial and low-irritating cosmetic | |
| JPH10203991A (en) | Preparation for external use for skin | |
| JPH11302147A (en) | Cosmetic | |
| JP3562781B2 (en) | Antibacterial hypoallergenic cosmetics | |
| JPH107582A (en) | Skin lotion | |
| JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same | |
| JPH10194916A (en) | Antimicrobial and low-irritating cosmetic | |
| JP3586519B2 (en) | Antibacterial hypoallergenic cosmetics | |
| JPH10182335A (en) | Antimicrobial and low-irritation cosmetic | |
| JPH09241142A (en) | Skin external agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20051214 |
|
| RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20051215 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20051215 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100113 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100113 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110113 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110113 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120113 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130113 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130113 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140113 Year of fee payment: 8 |
|
| LAPS | Cancellation because of no payment of annual fees |